INTELLECTUAL PROPERTY

FDA Rule for Generic Drug Labels Would Alter Scope for Tort Liability

, New Jersey Law Journal

   | 0 Comments

A proposed FDA rule, if adopted, would change the current drug-labeling process significantly and impose new requirements and costs on generic drug manufacturers.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202652321079

Thank you!

This article's comments will be reviewed.